Security Snapshot

AVADEL PHARMACEUTICALS PLC - Ordinary Shares, nominal value $0.01 per share (AVDL) Institutional Ownership

CUSIP: G29687103

13F Institutional Holders and Ownership History from Q1 2023 to Q2 2026

13F reference period

n/a

Institutions Reporting

Shares (Excl. Options)

n/a

Price

$21.69

The headline uses the Q3 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Shares outstanding
95,992,895
SEC-reported price per share
$21.69
Insider filing price
$21.69
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • AVDL - AVADEL PHARMACEUTICALS PLC - Ordinary Shares, nominal value $0.01 per share is tracked under CUSIP G29687103.
  • 13F reference-period holder data is not available.
  • 4 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder data for the Q3 2026 reference period is not available.
  • Available periods remain in the history table; they do not substitute for the headline period.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Schedule 13D/G

Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.

Open SEC evidence

Security key

G29687103

13F reference period

n/a

13F holders

13D/G owners

4

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
4
Security
AVDL
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 7% $59,674,993 6,742,480 BlackRock, Inc. 30 Jun 2025
VANGUARD GROUP INC 5.7% $49,243,692 5,564,259 The Vanguard Group 30 Jun 2025
JANUS HENDERSON GROUP PLC 1.9% -72% $39,176,620 -$120,413,722 1,823,865 -75% JANUS HENDERSON GROUP PLC 31 Dec 2025
BRANDES INVESTMENT PARTNERS, LP 0.2% -95% $4,700,576 -$117,105,674 218,835 -96% BRANDES INVESTMENT PARTNERS, LP 31 Dec 2025

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
12
Headline period
n/a
Rows shown
1-12 of 12
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q2 0 $0 -$426 $21.69 0
2026 Q1 20 $426 -$1,442,156,498 $21.30 1
2025 Q4 73,576,940 $1,585,325,518 -$27,117,037 $21.55 207
2025 Q3 79,038,211 $1,206,765,098 -$19,096,496 $15.27 183
2025 Q2 80,502,710 $712,425,370 +$33,247,786 $8.85 166
2025 Q1 77,015,539 $605,345,850 -$36,026,238 $7.83 169
2024 Q4 78,709,574 $827,347,590 +$46,727,000 $10.51 153
2024 Q3 73,371,084 $962,302,695 +$83,134,728 $13.12 169
2024 Q2 66,234,240 $931,472,460 +$905,737,723 $14.06 142
2024 Q1 1,624,846 $27,443,649 +$27,443,649 $16.89 7
2023 Q2 0 $0 -$4,287 $21.69 0
2023 Q1 468 $4,287 +$4,287 $9.16 1
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .